Tango Therapeutics (TNGX) had the highest return between March 3, 2026 and March 30, 2026 by a mid-cap US stock, returning 72.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Tango Therapeutics (TNGX) | 3/3/2026 - 3/30/2026 | 72.44% |
BitVentures (BVC) | 3/3/2026 - 3/30/2026 | 57.09% |
Dianthus Therapeutics (DNTH) | 3/3/2026 - 3/30/2026 | 47.57% |
Avis Budget (CAR) | 3/3/2026 - 3/30/2026 | 46.5% |
Sasol (SSL) | 3/3/2026 - 3/30/2026 | 45.18% |
Oruka Therapeutics (ORKA) | 3/3/2026 - 3/30/2026 | 40.06% |
CVR Energy (CVI) | 3/3/2026 - 3/30/2026 | 39.37% |
Par Pacific (PARR) | 3/3/2026 - 3/30/2026 | 37.21% |
Veradermics (MANE) | 3/3/2026 - 3/30/2026 | 37.17% |
Alpha Metallurgical Resources (AMR) | 3/3/2026 - 3/30/2026 | 34.56% |
Stagwell (STGW) | 3/3/2026 - 3/30/2026 | 34.34% |
Celanese (CE) | 3/3/2026 - 3/30/2026 | 34.27% |
Xenon Pharmaceuticals (XENE) | 3/3/2026 - 3/30/2026 | 33.69% |
SM Energy (SM) | 3/3/2026 - 3/30/2026 | 32.86% |
Calumet Specialty Products Partners (CLMT) | 3/3/2026 - 3/30/2026 | 30.41% |
Kodiak Sciences (KOD) | 3/3/2026 - 3/30/2026 | 30.36% |
Vista Energy, SAB de CV (VIST) | 3/3/2026 - 3/30/2026 | 29.75% |
Braze (BRZE) | 3/3/2026 - 3/30/2026 | 29.56% |
Telix Pharmaceuticals (TLX) | 3/3/2026 - 3/30/2026 | 29.11% |
Chord Energy (CHRD) | 3/3/2026 - 3/30/2026 | 29.01% |
Enliven Therapeutics (ELVN) | 3/3/2026 - 3/30/2026 | 27.62% |
John Wiley & Sons (WLY) | 3/3/2026 - 3/30/2026 | 26.41% |
AXT (AXTI) | 3/3/2026 - 3/30/2026 | 26.09% |
Navan, Inc Class A Common Stock (NAVN) | 3/3/2026 - 3/30/2026 | 25.95% |
Patterson-UTI Energy (PTEN) | 3/3/2026 - 3/30/2026 | 25.71% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.